The EntoEngine™

Our fruit fly biotechnology

Drosophila melanogaster Future Fields EntoEngine™

Fly by design

Our biomanufacturing platform, the EntoEngine™, uses the common fruit fly (Drosophila melanogaster) as its protein expression system.

 

Building on a century of genetics research, Future Fields is the first in the world to harness fruit flies for commercial recombinant protein production.

Why Drosophila?

Affordable development and production of proteins

Unbeatable capacity due to scalable, bioreactor-free system

Flexibility of protein development due to whole insect system

Simple bioprocessing with serum-free output

Future Fields Genetics Lead working with Drosophila melanogaster for protein expression

Enabling great science

"Future Fields is a shining example of what is incredible about the innovation driving the bioeconomy. Using fruit flies as ‘factories’ for recombinant proteins is an ingenious approach to bringing more scalable and sustainable solutions to biomanufacturing."

 

- Dr. John Cumbers, founder and CEO of SynBioBeta

Our EntoEngine™ in action

Your next ethical purchase

Our fly-based growth factors earned the ACT Label in 2023 and are made in Green-certified lab

The data is in

Recombinant human FGF2 made by Future Fields' EntoEngine™ shows high performance

Our platform, your technical advantage

Our biotechnology can produce your custom protein at scale

Our biomanufacturing process

What are your key advantages for producing recombinant proteins with the EntoEngine™?

Find out at our upcoming webinar!

Flying around the world

How we deploy the EntoEngine™ to make your proteins

Future Fields EntoEngine™ protein production process step 1
Future Fields EntoEngine™ protein production process step 2
Future Fields EntoEngine™ protein production process step 3
Future Fields EntoEngine™ protein production process step 4
Future Fields EntoEngine™ protein production process step 5
Future Fields EntoEngine™ protein production process step 6
Future Fields EntoEngine™ protein production process step 7
Future Fields EntoEngine™ protein production process step 8
Future Fields EntoEngine™ protein production process step 9
Future Fields EntoEngine™ protein production process step 10

Click through this 10-slide overview to learn how we produce recombinant proteins with our whole-insect system.

Our EntoEngine™ makes reagents for the sustainable scientist.

Our EntoEngine™ makes custom protein solutions easy, affordable, and better for the planet.

We invest in the quality of our proteins. Our robust quality department and positive quality culture is supported by a Quality management system built on pharma-compliant software.

 

For custom protein solutions, we can accommodate quality standards that range from research use only to pre-clinical needs.

Acting on the climate crisis is one of Future Fields' core values. Through our growing suite of initiatives, we hope to raise the bar for biotech in reducing our collective environmental footprint.

Proudly funded by

Bee Partners Future Fields
Toyota Ventures Future Fields
Builders VC Future Fields
AgFunder Future Fields
Amplify Capital Future Fields
BoxOne Future Fields
Green Circle Foodtech Ventures Future Fields
Siddhi Capital Future Fields
Climate Capital Future Fields
Y Combinator Future Fields
Keiki Capital Future Fields
Pioneer Fund Future Fields
Startup TNT Future Fields

The next evolution of biomanufacturing

For scientists, by scientists.

 

Synergizing nature and technology to improve life on Earth.